Variability of Cerebral MRI Diffusion Parameters by Using a Patented Normalization Process vs no Use

NCT ID: NCT05446922

Last Updated: 2023-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-30

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

BrainTale has developed a standardization approach based on averaging measurements in predefined brain regions of interest and use of reference data acquired from healthy volunteers under conditions (MRI machine, acquisition protocol) identical to those used for the examination of the patient. The present study is intended to support the normalization step on healthy volunteers in clinical centres that will be equipped with the BrainTale medical device software dedicated to clinical routine practice and to assess, through a multicentre study, the impact of this normalization step on the variability of the MRI diffusion parameters. The data collected will support characterization and modelisation of the variability to explore further biais corrections methods. The study will be conducted by neuroradiologists of the neuroradiology departments of five clinical centres in France.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Advances in medical imaging have made it possible, from the 1990s, to be able to visualize structural microlesions of the brain thanks to post-processing of the Magnetic Resonance Imaging (MRI) data acquired by the sequence using the diffusion tensor. Mathematical models such as the diffusion tensor have made it possible to quantify in each of the volumetric units of the brain (voxels) measurements correlated to the microstructure of neuronal axons such as the Fractional Anisotropy (FA), the Mean Diffusivity (MD), the Radial Diffusivity (RD) or the Axial Diffusivity (AD). These measurements thus make it possible to quantify the microstructural alterations.

However, the use of Diffusion Tensor Imaging (DTI) technology has limitations and currently, there is no "gold-standard" to validate diffusion measurements, which are currently dependent on acquisition protocols, post-processing software and observers.

To make these diffusion parameters usable in a clinical context, BrainTale has developed a standardization approach based on averaging measurements in predefined brain regions of interest and use of reference data acquired from healthy volunteers under conditions (MRI machine, acquisition protocol) identical to those used for the examination of the patient. This process requires the acquisition of 10 healthy volunteers to calibrate a new MRI protocol, which greatly limits access to the technology in clinical routine and limits the potential technological evolutions of the acquisition.

The study aims to assess the impact of a patented normalization process on the interindividual variability of Fractional Anisotropy (FA) measurements derived from cerebral Diffusion Tensor Imaging (DTI) acquisitions.

A total of 60 healthy volunteers will be included. One or two acquisition will be performed during a single on-site visit in order to collect diffusion parameters outcome data for further analyses (with or without normalization process).

After each acquisition and before inclusion of the following healthy volunteer, anonymised subject's data will be transferred to BrainTale on a secured web platform. BrainTale will be in charge of the Quality Control (QC) of the acquired data and will attribute a QC-passed or QC-failed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain MRI

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MRI imaging of 10 healthy volunteers

10 healthy volunteers will proceed at an brain MRI imaging

Group Type OTHER

Diffusion MRI

Intervention Type OTHER

All procedures will be performed during a single visit. Subjects will be invited to lie on the scanning bed that will be moved head first into the scanner such as the head lie under the scanner magnets. Hearing protection will be provided to each subject to muffle the noise produced by the MRI scanner. Subjects will also be provided with pillows and blankets to keep them comfortable. They will also be given a call button that they can push to stop the procedure at any time. MRI acquisition will be performed on 1.5T or 3.0T MRI scanners depending on centre's equipment. Acquisition protocol will include the following sequences with the best parameters chosen by local radiologist and technical BrainTale team.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diffusion MRI

All procedures will be performed during a single visit. Subjects will be invited to lie on the scanning bed that will be moved head first into the scanner such as the head lie under the scanner magnets. Hearing protection will be provided to each subject to muffle the noise produced by the MRI scanner. Subjects will also be provided with pillows and blankets to keep them comfortable. They will also be given a call button that they can push to stop the procedure at any time. MRI acquisition will be performed on 1.5T or 3.0T MRI scanners depending on centre's equipment. Acquisition protocol will include the following sequences with the best parameters chosen by local radiologist and technical BrainTale team.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female aged 18 up to 80 years old
2. Covered by a healthcare insurance
3. Agreeing to be informed about any incidental finding discovered on brain MRI
4. Written informed consent form signed

Exclusion Criteria

1. History of brain pathology, cognitive or psychiatric disorder
2. Any contraindication \* for undergoing brain MRI
3. Subject refusing to participate or having expressed refusal to data collection/processing or unable to give his/her agreement to participate
4. Vulnerable subject (i.e. pregnant or breast-feeding woman, child, subject under curatorship or deprived of liberty)

* contraindications to MRI include: pacemaker, neural stimulator, intraocular or intracerebral device, cochlear implant, MR-incompatible prosthetic heart valves, any implant with metallic, ferromagnetic or electrically conductive parts, any metal in the body which cannot be removed, claustrophobia.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Braintale

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

PERLBARG Vincent

Role: STUDY_CHAIR

Braintale

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

URIET Dorothée

Role: CONTACT

+33686116089

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A00622-41

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Study of Imaging in Demyelinating Diseases
NCT05805839 ENROLLING_BY_INVITATION PHASE2